Which has the lower trailing P/E, AZN or HUM?

AZN has the lower trailing P/E: AZN trades at 24.05 and HUM at 38.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or HUM?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus HUM at 12.61%.

Does AZN or HUM pay a bigger dividend?

AZN yields 2.02% and HUM yields 0.88% based on trailing dividends and the latest price.

Is AZN or HUM more profitable?

AZN runs the higher net margin — AZN at 17.02% versus HUM at 0.88%.

How have AZN and HUM total returns compared?

Over the past 10 years, AZN delivered 12.85% and HUM delivered 9.46% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Humana Inc. (HUM)

A side-by-side comparison of AstraZeneca PLC and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$248.40B

$160.17HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

HUM

Humana Inc.

$49.21B

$409.85HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — AZN vs HUM

growth of $100 · dividends reinvested · last 10y

AZN +217.1% (+12.2%/yr)HUM +147.2% (+9.5%/yr)AZN compounded faster over this window

AZN HUM

AZN vs HUM: by the numbers

•AZN is the larger company ($248.40B vs $49.21B market cap).
•AZN trades at the lower trailing earnings multiple (24.05 vs 38.81 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.02% vs 0.88% net margin).
•AZN grew revenue faster over the past five years (15.76% vs 12.61% CAGR).
•AZN pays the higher dividend yield (2.02% vs 0.88%).

Metrics side by side

Valuation

Metric	AZN	HUM
P/E ratio	24.05	38.81
Forward P/E	15.64	44.77
P/S ratio	4.05	0.34
P/B ratio	4.94	2.56
EV / EBITDA	13.56	20.40
FCF yield	3.52%	N/A

Profitability

Metric	AZN	HUM
Gross margin	81.88%	13.65%
Operating margin	22.77%	1.39%
Net margin	17.02%	0.88%
ROE	20.79%	6.65%
ROIC	12.83%	4.52%

Dividends

Metric	AZN	HUM
Dividend yield	2.02%	0.88%
Payout ratio	48.50%	33.52%

Growth (annualized)

Metric	AZN	HUM
Revenue CAGR (5Y)	15.76%	12.61%
EPS CAGR (5Y)	22.02%	-17.27%
FCF CAGR (5Y)	14.53%	-17.19%
Total return CAGR (5Y)	9.46%	0.94%

Frequently asked

Which has the lower trailing P/E, AZN or HUM?: AZN has the lower trailing P/E: AZN trades at 24.05 and HUM at 38.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or HUM?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus HUM at 12.61%.
Does AZN or HUM pay a bigger dividend?: AZN yields 2.02% and HUM yields 0.88% based on trailing dividends and the latest price.
Is AZN or HUM more profitable?: AZN runs the higher net margin — AZN at 17.02% versus HUM at 0.88%.
How have AZN and HUM total returns compared?: Over the past 10 years, AZN delivered 12.85% and HUM delivered 9.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Humana P/E ratio AstraZeneca dividend yield Humana dividend yield AstraZeneca ROE Humana ROE AstraZeneca operating margin Humana operating margin AstraZeneca revenue growth Humana revenue growth AstraZeneca free cash flow Humana free cash flow

AstraZeneca & Humana appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.